Lars G Hemkens
Characteristics and survival of patients with cancer with intended off-label use-a cohort study.
Schmitt A, Walter M, Herbrand A, Jörger M, Moffa G, Novak U, Hemkens L, Kasenda B. Characteristics and survival of patients with cancer with intended off-label use-a cohort study. BMJ Open 2022; 12:e060453.
24.05.2022Characteristics and survival of patients with cancer with intended off-label use-a cohort study.
24.05.2022BMJ Open 2022; 12:e060453
Schmitt Andreas Michael, Walter Martin A, Herbrand Amanda Katherina, Jörger Markus, Moffa Giusi, Novak Urban, Hemkens Lars G, Kasenda Benjamin
Association of the COVID-19 outbreak with acute stroke care in Switzerland.
De Marchis G, Wright P, Michel P, Strambo D, Carrera E, Dirren E, Luft A, Wegener S, Cereda C, Kägi G, Vehoff J, Gensicke H, Lyrer P, Nedeltchev K, Khales T, Bolognese M, Salmen S, Sturzenegger R, Bonvin C, Berger C, Schelosky L, Mono M, Rodic B, von Reding A, Schwegler G, Tarnutzer A, Medlin F, Humm A, Peters N, Beyeler M, Kriemler L, Bervini D, Fandino J, Hemkens L, Mordasini P, Arnold M, Fischer U, Bonati L, Swiss Stroke Registry Investigators. Association of the COVID-19 outbreak with acute stroke care in Switzerland. Eur J Neurol 2022; 29:724-731.
04.01.2022Association of the COVID-19 outbreak with acute stroke care in Switzerland.
04.01.2022Eur J Neurol 2022; 29:724-731
De Marchis Gian Marco, Wright Patrick R, Michel Patrik, Strambo Davide, Carrera Emmanuel, Dirren Elisabeth, Luft Andreas R, Wegener Susanne, Cereda Carlo W, Kägi Georg, Vehoff Jochen, Gensicke Henrik, Lyrer Philippe A, Nedeltchev Krassen, Khales Timo, Bolognese Manuel, Salmen Stephan, Sturzenegger Rolf, Bonvin Christophe, Berger Christian, Schelosky Ludwig D., Mono Marie-Luise, Rodic Biljana, von Reding Andrea, Schwegler Guido, Tarnutzer Alexander A., Medlin Friedrich, Humm Andrea M, Peters Nils, Beyeler Morin, Kriemler Lilian, Bervini David, Fandino Javier, Hemkens Lars G, Mordasini Pasquale, Arnold Marcel, Fischer Urs, Bonati Leo H, Swiss Stroke Registry Investigators
Association of Supporting Trial Evidence and Reimbursement for Off-Label Use of Cancer Drugs
Herbrand A, Hemkens L, Novak U, Moffa G, Jörger M, Hoogkamer A, Diem S, Goldkuhle M, Ewald H, Briel M, Schmitt A, Kasenda B. Association of Supporting Trial Evidence and Reimbursement for Off-Label Use of Cancer Drugs. JAMA Netw Open 2021; 4:e210380.
01.03.2021Association of Supporting Trial Evidence and Reimbursement for Off-Label Use of Cancer Drugs
01.03.2021JAMA Netw Open 2021; 4:e210380
Herbrand Amanda Katherina, Hemkens Lars G, Novak Urban, Moffa Giusi, Jörger Markus, Hoogkamer Anouk, Diem Stefan, Goldkuhle Marius, Ewald Hannah, Briel Matthias, Schmitt Andreas M, Kasenda Benjamin
Contrasting evidence to reimbursement reality for off-label use (OLU) of drug treatments in cancer care: rationale and design of the CEIT-OLU project
Herbrand A, Hemkens L, Sricharoenchai S, Novak U, Mc Cord K, Jörger M, Hoogkamer A, Ewald H, Diem S, Briel M, Schmitt A, Kasenda B. Contrasting evidence to reimbursement reality for off-label use (OLU) of drug treatments in cancer care: rationale and design of the CEIT-OLU project. ESMO Open 2019; 4:e000596.
01.12.2019Contrasting evidence to reimbursement reality for off-label use (OLU) of drug treatments in cancer care: rationale and design of the CEIT-OLU project
01.12.2019ESMO Open 2019; 4:e000596
Herbrand Amanda Katherina, Hemkens Lars G, Sricharoenchai Sirintip, Novak Urban, Mc Cord Kimberly Alba, Jörger Markus, Hoogkamer Anouk, Ewald Hannah, Diem Stefan, Briel Matthias, Schmitt Andreas Michael, Kasenda Benjamin